Pharmaceutical compositions containing lipase inhibitor
    1.
    发明授权
    Pharmaceutical compositions containing lipase inhibitor 有权
    含有脂肪酶抑制剂的药物组合物

    公开(公告)号:US06358522B1

    公开(公告)日:2002-03-19

    申请号:US09370846

    申请日:1999-08-10

    IPC分类号: A61K928

    摘要: The present invention provides orally administrable pharmaceutical compositions containing an inhibitor of gastrointestinal lipase, one (or more) additive(s) of the group consisting of substantially non-digestible, substantially non-fermentable, hydrophilic and/or hydrocolloidal food grade thickeners and emulsifiers, and auxiliary excipients. Methods are provided for preventing and treating anal leakage of oil in a patient by administering the compositions of the present invention to the patient.

    摘要翻译: 本发明提供了可口服给药的药物组合物,其含有胃肠脂肪酶抑制剂,一种(或多种)添加剂,其由基本上不可消化的,基本上不可发酵的,亲水的和/或水解胶体的食品级增稠剂和乳化剂组成, 和辅助赋形剂。 提供了通过将本发明的组合物给予患者来预防和治疗患者的油的肛门泄漏的方法。

    Naphthalenylmethoxypiperidines as renin inhibitors
    4.
    发明授权
    Naphthalenylmethoxypiperidines as renin inhibitors 失效
    萘基哌啶作为肾素抑制剂

    公开(公告)号:US06376672B1

    公开(公告)日:2002-04-23

    申请号:US09542303

    申请日:2000-04-04

    IPC分类号: C07D21142

    摘要: The present invention relates to compound of formula (I) wherein R1, R2 and R3 are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for treating diseases associated with restenosis, glaucoma, cardiac infarct, high blood pressure and end organ damage, e.g. cardiac insufficiency and kidney insufficiency.

    摘要翻译: 本发明涉及式(I)化合物,其中R 1,R 2和R 3如说明书和权利要求及其药学上可接受的盐所定义。 这些化合物可用于治疗与再狭窄,青光眼,心肌梗塞,高血压和终末器官损害相关的疾病,例如, 心功能不全和肾功能不全。

    Piperidine derivatives
    5.
    发明授权
    Piperidine derivatives 失效
    哌啶衍生物

    公开(公告)号:US06197959B1

    公开(公告)日:2001-03-06

    申请号:US09542598

    申请日:2000-04-04

    IPC分类号: A61K3147

    CPC分类号: C07D401/12 C07D401/14

    摘要: Compounds of formula (I) wherein R1 and R2 are as defined in the description and claims and pharmaceutically acceptable salts thereof, are useful for the treating diseases associated with restenosis, glaucoma, cardiac infarct, high blood pressure and end organ damage, for example, cardiac insufficiency and kidney insufficiency.

    摘要翻译: 其中R 1和R 2如说明书和权利要求及其药学上可接受的盐中所定义的式(I)化合物可用于治疗与再狭窄,青光眼,心肌梗死,高血压和终末器官损害相关的疾病,例如, 心功能不全和肾功能不全。